InsidersTradesSigma
Pharmaron Beijing Co., Ltd. Stock: price and directors' dealings · Hong Kong · HKEX
Follow the Pharmaron Beijing Co., Ltd. stock price and the full insider trade history of the company, a listed equity based in Hong Kong. Shares are listed on HK HK, under the supervision of HKEX. Operating in the Health Care sector, Pharmaron Beijing Co., Ltd. has logged 4 public disclosures. Market capitalisation: €27.8bn. The latest transaction was reported on 6 May 2026 (Other). Among the most active insiders: Lou Xiaoqiang. The full history is free.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Pharmaron Beijing Co., Ltd. Strong Buy (bullish), based on 11 analysts. Average price target: HK$30.25.
6Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 12,703 of 26,212 companies
52.8
score / 100
Value47
Quality59
FCF yld1.3%
Earn yld4.0%
EV/EBITDA14.9x
ROE10.0%
Gross mgn35%
Net mgn12%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 May 2026
Declarations4 total
4,450,000 sharesShareXHKGHKEX:DA20260506E00308
4,700,000 sharesShareXHKGHKEX:DA20260506E00307
11,000,000 sharesShareXHKGHKEX:DA20260430E00043
11,000,000 sharesShareXHKGHKEX:DA20260430E00044
4 of 4 declarations